Profile
| Metric | Value |
|---|---|
| Full Name | Edwards Lifesciences Corporation |
| Ticker | NYSE: EW |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | edwards.com |
| Employees | 15,800 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $85.33 | |
| Price, 1D Change | +0.09% | |
| Market Cap | $50B | |
| - | ||
| PE Ratio | 36.33 | |
| Beta | 0.52 | |
| Revenue | $5B | |
| Revenue, 1Y Change | +8.57% | |
| EPS | $1.46 | |
| EPS, 1Y Change | -36.58% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 3:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.46 | |
| EPS Estimate | $2.58 | |
| EPS Est. Change | +77.06% | |
| Revenue | $5.44B | |
| Revenue Estimate | $6.03B | |
| Revenue Est. Change | +10.89% | |
| Current Price | $85.33 | |
| Price Target | - | $97.50 |
| Price Tgt. Change | - | +14.26% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.51 | $2.30 | -8.31% | |
| $2.55 | $1.46 | -42.67% | |
| $2.58 | N/A | +77.06% | |
| $2.87 | N/A | +96.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.97B | $5.01B | -16.04% | |
| $5.91B | $5.44B | -7.91% | |
| $6.03B | N/A | +10.89% | |
| $6.62B | N/A | +21.63% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +17.55% | |
| Price, 3Y | +14.37% | |
| Market Cap, 1Y | +15.89% | |
| Market Cap, 3Y | +9.10% | |
| Revenue, 1Y | +8.57% | |
| Revenue, 3Y | +3.96% | |
| EPS, 1Y | -36.58% | |
| EPS, 3Y | -38.71% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $85.33 | |
| SMA 200 | $78.01 | |
| SMA 200 vs Price | -8.57% | |
| SMA 50 | $84.23 | |
| SMA 50 vs Price | -1.29% | |
| Beta | 0.52 | |
| ATR | $1.50 | |
| 14-Day RSI | 51.47 | |
| 10-Day Volatility | 11.26% | |
| 1-Year Volatility | 23.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $5.44B | |
| EPS | $1.46 | |
| Gross Profit | $4.29B | |
| Gross Margin | 78.80% | |
| Operating Profit | $1.44B | |
| Operating Margin | 26.55% | |
| Net Income | $1.40B | |
| Net Margin | 25.66% | |
| EBITDA | $1.60B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.07 | |
| Current Ratio | 4.18 | |
| Quick Ratio | 3.45 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 12.56 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 36.33 | |
| PS Ratio | 8.42 | |
| PB Ratio | 4.85 | |
| EV/EBITDA | 26.31 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $10.00B | |
| Cash & Equivalents | $3.98B | |
| Total Assets | $13.06B | |
| Current Assets | $6.29B | |
| Total Liabilities | $2.99B | |
| Current Liabilities | $1.51B | |
| Total Debt | $700.00M | |
| Short Term Debt | $23.40M | |
| Accounts Payable | $197.40M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $4.04B | |
| Operating Expenses | $2.84B | |
| Cost Of Goods Sold | $1.15B | |
| SG&A | $0.00 | |
| D&A | $155.20M | |
| Interest Expense | $0.00 | |
| Income Tax | $152.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $542.30M | |
| CFI | $2.31B | |
| CFF | -$983.00M | |
| Capex | $282.40M | |
| Free Cash Flow | $259.90M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Canaccord Genuity | → | |
| Baird | → | |
| Citigroup | → | |
| Barclays | → | |
| Wells Fargo | → | |
| UBS | → | |
| Truist Securities | → | |
| Stifel | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with EW
Data Sources & References
- EW Official Website www.edwards.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1099800/000109980025000062/0001099800-25-000062-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1099800/000109980025000005/0001099800-25-000005-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- EW Profile on Yahoo Finance finance.yahoo.com/quote/EW
- EW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ew
FAQ
What is the ticker symbol for Edwards Lifesciences Corporation?
The ticker symbol for Edwards Lifesciences Corporation is NYSE:EW
Does Edwards Lifesciences Corporation pay dividends?
No, Edwards Lifesciences Corporation does not pay dividends
What sector is Edwards Lifesciences Corporation in?
Edwards Lifesciences Corporation is in the Healthcare sector
What industry is Edwards Lifesciences Corporation in?
Edwards Lifesciences Corporation is in the Medical Devices industry
What country is Edwards Lifesciences Corporation based in?
Edwards Lifesciences Corporation is headquartered in United States
When did Edwards Lifesciences Corporation go public?
Edwards Lifesciences Corporation initial public offering (IPO) was on March 27, 2000
Is Edwards Lifesciences Corporation in the S&P 500?
Yes, Edwards Lifesciences Corporation is included in the S&P 500 index
Is Edwards Lifesciences Corporation in the NASDAQ 100?
No, Edwards Lifesciences Corporation is not included in the NASDAQ 100 index
Is Edwards Lifesciences Corporation in the Dow Jones?
No, Edwards Lifesciences Corporation is not included in the Dow Jones index
When was Edwards Lifesciences Corporation last earnings report?
Edwards Lifesciences Corporation's most recent earnings report was on October 30, 2025
When does Edwards Lifesciences Corporation report earnings?
The next expected earnings date for Edwards Lifesciences Corporation is February 11, 2026
